Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01025674 · ClinicalTrials.gov registry record · NA
Randomized Trial of the Positive Action Program in Chicago Schools and Extension to Grade 8
A NA study, sponsored by Oregon State University.
- Completed
- Registry status
- NA
- Development phase
- 4,230
- Enrollment target
NCT01025674: Completed NA study, sponsored by Oregon State University.
NCT01025674 is a NA study that has completed, run by Oregon State University. The registered enrollment target is 4,230 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (201% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01025674, a NA study, has completed, sponsored by Oregon State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,230 participants
- Enrollment target
Study Summary
This project focuses on social and character development of elementary and middle school-aged children and responds to an urgent national need that schools improve their capacity to address a range of student outcomes, including social skills, character, behavior, academic achievement and health outcomes. This study is a school-based randomized trial to evaluate the Positive Action program. The Positive Action program was designed to promote social and character development and improve behavior and school performance.
Interventions
- BEHAVIORAL Positive Action program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,230 participants |
| Start Date | 2004-09 |
| Est. Completion | 2010-06 |
| Phase | NA |
What the finished NCT01025674 record still lists
NCT01025674 is an interventional study that assigns participants to a tested intervention. Its 4,230 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (201% higher).
The record links to 0 conditions, and to 1 intervention - of which Positive Action program is the first listed.
NCT01025674 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01025674 about?
NCT01025674 is a clinical study titled "Randomized Trial of the Positive Action Program in Chicago Schools and Extension to Grade 8". This project focuses on social and character development of elementary and middle school-aged children and responds to an urgent national need that schools improve their capacity to address a range of student outcomes, including social skills, character, behavior, academic achievement and health out...
What is the current status of trial NCT01025674?
This trial is currently completed. It is a NA study. The enrollment target is 4,230 participants. The study started on 2004-09. Estimated completion is 2010-06.
What interventions are being tested in trial NCT01025674?
The interventions under investigation include: Positive Action program (BEHAVIORAL).
Who is sponsoring clinical trial NCT01025674?
This trial is sponsored by Oregon State University, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01025674's enrollment target sits among peer trials
4,230 30th of 2000 higher than 1,971 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06492616 · 4,220 participants · Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
- NCT06935370 · 4,200 participants · Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia